Positive and Negative Signaling through SLAM Receptors Regulate Synapse Organization and Thresholds of Cytolysis

Immunity

Volumn 36, Issue 6, 2012, Pages 1003-1016

  Zhao, Fang ^a,b   Cannons, Jennifer L ^a   Dutta, Mala ^a   Griffiths, Gillian M ^b   Schwartzberg, Pamela L ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2B4 PROTEIN; CD150 ANTIGEN; LY108 PROTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CELL ADHESION; CONTROLLED STUDY; CYTOLYSIS; ENZYME LOCALIZATION; FIBROSARCOMA; IMMUNOLOGICAL SYNAPSE; IMMUNOREGULATION; INTRACELLULAR SIGNALING; LYMPHOCYTOTOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TARGET CELL;

ACTINS; ANIMALS; ANTIGENS, CD; ANTIGENS, LY; B-LYMPHOCYTES; CELL ADHESION; CELL LINE, TUMOR; CENTROSOME; CYTOSKELETON; CYTOTOXICITY, IMMUNOLOGIC; FIBROSARCOMA; IMMUNOLOGICAL SYNAPSES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA, T-CELL; MICE; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, IMMUNOLOGIC; SRC-FAMILY KINASES; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84863001429     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.05.017     Document Type: Article

References (56)

1. Beal A.M., Anikeeva N., Varma R., Cameron T.O., Vasiliver-Shamis G., Norris P.J., Dustin M.L., Sykulev Y. Kinetics of early T cell receptor signaling regulate the pathway of lytic granule delivery to the secretory domain. Immunity 2009, 31:632-642.
2. Booth C., Gilmour K.C., Veys P., Gennery A.R., Slatter M.A., Chapel H., Heath P.T., Steward C.G., Smith O., O'Meara A., et al. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood 2011, 117:53-62.
3. Bottino C., Falco M., Parolini S., Marcenaro E., Augugliaro R., Sivori S., Landi E., Biassoni R., Notarangelo L.D., Moretta L., Moretta A. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 2001, 194:235-246.
4. Brossard C., Feuillet V., Schmitt A., Randriamampita C., Romao M., Raposo G., Trautmann A. Multifocal structure of the T cell - dendritic cell synapse. Eur. J. Immunol. 2005, 35:1741-1753.
5. Campi G., Varma R., Dustin M.L. Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling. J. Exp. Med. 2005, 202:1031-1036.
6. Cannons J.L., Yu L.J., Hill B., Mijares L.A., Dombroski D., Nichols K.E., Antonellis A., Koretzky G.A., Gardner K., Schwartzberg P.L. SAP regulates T(H)2 differentiation and PKC-θ-mediated activation of NF-kappaB1. Immunity 2004, 21:693-706.
7. Cannons J.L., Qi H., Lu K.T., Dutta M., Gomez-Rodriguez J., Cheng J., Wakeland E.K., Germain R.N., Schwartzberg P.L. Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity 2010, 32:253-265.
8. Cannons J.L., Tangye S.G., Schwartzberg P.L. SLAM family receptors and SAP adaptors in immunity. Annu. Rev. Immunol. 2011, 29:665-705.
9. Cemerski S., Das J., Giurisato E., Markiewicz M.A., Allen P.M., Chakraborty A.K., Shaw A.S. The balance between T cell receptor signaling and degradation at the center of the immunological synapse is determined by antigen quality. Immunity 2008, 29:414-422.
10. Chan B., Lanyi A., Song H.K., Griesbach J., Simarro-Grande M., Poy F., Howie D., Sumegi J., Terhorst C., Eck M.J. SAP couples Fyn to SLAM immune receptors. Nat. Cell Biol. 2003, 5:155-160.
11. Chiang G.G., Sefton B.M. Specific dephosphorylation of the Lck tyrosine protein kinase at Tyr-394 by the SHP-1 protein-tyrosine phosphatase. J. Biol. Chem. 2001, 276:23173-23178.
12. Coffey A.J., Brooksbank R.A., Brandau O., Oohashi T., Howell G.R., Bye J.M., Cahn A.P., Durham J., Heath P., Wray P., et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 1998, 20:129-135.
13. Czar M.J., Kersh E.N., Mijares L.A., Lanier G., Lewis J., Yap G., Chen A., Sher A., Duckett C.S., Ahmed R., Schwartzberg P.L. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proc. Natl. Acad. Sci. USA 2001, 98:7449-7454.
14. Daniels M.A., Teixeiro E., Gill J., Hausmann B., Roubaty D., Holmberg K., Werlen G., Holländer G.A., Gascoigne N.R., Palmer E. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature 2006, 444:724-729.
15. Davis D.M., Chiu I., Fassett M., Cohen G.B., Mandelboim O., Strominger J.L. The human natural killer cell immune synapse. Proc. Natl. Acad. Sci. USA 1999, 96:15062-15067.
16. De Salort J., Sintes J., Llinàs L., Matesanz-Isabel J., Engel P. Expression of SLAM (CD150) cell-surface receptors on human B-cell subsets: from pro-B to plasma cells. Immunol. Lett. 2011, 134:129-136.
17. + T cells against EBV-infected cells. Blood 2005, 105:4383-4389.
18. Eissmann P., Beauchamp L., Wooters J., Tilton J.C., Long E.O., Watzl C. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 2005, 105:4722-4729.
19. Feldmann J., Callebaut I., Raposo G., Certain S., Bacq D., Dumont C., Lambert N., Ouachée-Chardin M., Chedeville G., Tamary H., et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003, 115:461-473.
20. Freiberg B.A., Kupfer H., Maslanik W., Delli J., Kappler J., Zaller D.M., Kupfer A. Staging and resetting T cell activation in SMACs. Nat. Immunol. 2002, 3:911-917.
21. Griewank K., Borowski C., Rietdijk S., Wang N., Julien A., Wei D.G., Mamchak A.A., Terhorst C., Bendelac A. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 2007, 27:751-762.
22. + T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets. Blood 2010, 116:3249-3257.
23. Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J., Carbone F.R. T cell receptor antagonist peptides induce positive selection. Cell 1994, 76:17-27.
24. Howie D., Simarro M., Sayos J., Guirado M., Sancho J., Terhorst C. Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation. Blood 2002, 99:957-965.
25. Jameson S.C., Carbone F.R., Bevan M.J. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 1993, 177:1541-1550.
26. Kageyama R., Cannons J.L., Zhao F., Yusuf I., Lao C., Locci M., Schwartzberg P.L., Crotty S. The receptor Ly108 functions as a SAP adaptor-dependent on-off switch for T cell help to B cells and NKT cell development. Immunity 2012, Published online June 7, 2012. 10.1016/j.immuni.2012.05.016.
27. Kupfer H., Monks C.R., Kupfer A. Small splenic B cells that bind to antigen-specific T helper (Th) cells and face the site of cytokine production in the Th cells selectively proliferate: immunofluorescence microscopic studies of Th-B antigen-presenting cell interactions. J. Exp. Med. 1994, 179:1507-1515.
28. Latour S., Roncagalli R., Chen R., Bakinowski M., Shi X., Schwartzberg P.L., Davidson D., Veillette A. Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation. Nat. Cell Biol. 2003, 5:149-154.
29. Li C., Iosef C., Jia C.Y., Han V.K., Li S.S. Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP/SH2D1A in signaling through the signaling lymphocyte activation molecule (SLAM) family of immune receptors. J. Biol. Chem. 2003, 278:3852-3859.
30. Long E.O. Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol. Rev. 2008, 224:70-84.
31. + CTL function: similarities and differences between NKG2D and CD28 costimulation. J. Immunol. 2005, 175:2825-2833.
32. Monks C.R., Freiberg B.A., Kupfer H., Sciaky N., Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 1998, 395:82-86.
33. Nichols K.E., Harkin D.P., Levitz S., Krainer M., Kolquist K.A., Genovese C., Bernard A., Ferguson M., Zuo L., Snyder E., et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad. Sci. USA 1998, 95:13765-13770.
34. Palendira U., Low C., Chan A., Hislop A.D., Ho E., Phan T.G., Deenick E., Cook M.C., Riminton D.S., Choo S., et al. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP. PLoS Biol. 2011, 9:e1001187.
35. Parolini S., Bottino C., Falco M., Augugliaro R., Giliani S., Franceschini R., Ochs H.D., Wolf H., Bonnefoy J.Y., Biassoni R., et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 2000, 192:337-346.
36. Pfirsch-Maisonnas S., Aloulou M., Xu T., Claver J., Kanamaru Y., Tiwari M., Launay P., Monteiro R.C., Blank U. Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized " inhibisome" clusters. Sci. Signal. 2011, 4:ra24.
37. Qi H., Cannons J.L., Klauschen F., Schwartzberg P.L., Germain R.N. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature 2008, 455:764-769.
38. Ren L., Chen X., Luechapanichkul R., Selner N.G., Meyer T.M., Wavreille A.S., Chan R., Iorio C., Zhou X., Neel B.G., Pei D. Substrate specificity of protein tyrosine phosphatases 1B, RPTPα, SHP-1, and SHP-2. Biochemistry 2011, 50:2339-2356.
39. Riteau B., Barber D.F., Long E.O. Vav1 phosphorylation is induced by beta2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J. Exp. Med. 2003, 198:469-474.
40. Roda-Navarro P., Mittelbrunn M., Ortega M., Howie D., Terhorst C., Sánchez-Madrid F., Fernández-Ruiz E. Dynamic redistribution of the activating 2B4/SAP complex at the cytotoxic NK cell immune synapse. J. Immunol. 2004, 173:3640-3646.
41. Rosette C., Werlen G., Daniels M.A., Holman P.O., Alam S.M., Travers P.J., Gascoigne N.R., Palmer E., Jameson S.C. The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. Immunity 2001, 15:59-70.
42. Ryser J.E., Rungger-Brändle E., Chaponnier C., Gabbiani G., Vassalli P. The area of attachment of cytotoxic T lymphocytes to their target cells shows high motility and polarization of actin, but not myosin. J. Immunol. 1982, 128:1159-1162.
43. Sayos J., Wu C., Morra M., Wang N., Zhang X., Allen D., van Schaik S., Notarangelo L., Geha R., Roncarolo M.G., et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998, 395:462-469.
44. Schwartzberg P.L., Mueller K.L., Qi H., Cannons J.L. SLAM receptors and SAP influence lymphocyte interactions, development and function. Nat. Rev. Immunol. 2009, 9:39-46.
45. Sharifi R., Sinclair J.C., Gilmour K.C., Arkwright P.D., Kinnon C., Thrasher A.J., Gaspar H.B. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease. Blood 2004, 103:3821-3827.
46. Shlapatska L.M., Mikhalap S.V., Berdova A.G., Zelensky O.M., Yun T.J., Nichols K.E., Clark E.A., Sidorenko S.P. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J. Immunol. 2001, 166:5480-5487.
47. Smith C., Miles J.J., Khanna R. Advances in direct T-cell alloreactivity: function, avidity, biophysics and structure. Am. J. Transplant. 2012, 12:15-26.
48. Snow A.L., Marsh R.A., Krummey S.M., Roehrs P., Young L.R., Zhang K., van Hoff J., Dhar D., Nichols K.E., Filipovich A.H., et al. Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. J. Clin. Invest. 2009, 119:2976-2989.
49. Stebbins C.C., Watzl C., Billadeau D.D., Leibson P.J., Burshtyn D.N., Long E.O. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol. Cell. Biol. 2003, 23:6291-6299.
50. Stefanová I., Hemmer B., Vergelli M., Martin R., Biddison W.E., Germain R.N. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat. Immunol. 2003, 4:248-254.
51. Stinchcombe J.C., Bossi G., Booth S., Griffiths G.M. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 2001, 15:751-761.
52. Stinchcombe J.C., Majorovits E., Bossi G., Fuller S., Griffiths G.M. Centrosome polarization delivers secretory granules to the immunological synapse. Nature 2006, 443:462-465.
53. Tsun A., Qureshi I., Stinchcombe J.C., Jenkins M.R., de la Roche M., Kleczkowska J., Zamoyska R., Griffiths G.M. Centrosome docking at the immunological synapse is controlled by Lck signaling. J. Cell Biol. 2011, 192:663-674.
54. Varma R., Campi G., Yokosuka T., Saito T., Dustin M.L. T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity 2006, 25:117-127.
55. Vyas Y.M., Maniar H., Dupont B. Cutting edge: differential segregation of the SRC homology 2-containing protein tyrosine phosphatase-1 within the early NK cell immune synapse distinguishes noncytolytic from cytolytic interactions. J. Immunol. 2002, 168:3150-3154.
56. Zhong M.C., Veillette A. Control of T lymphocyte signaling by Ly108, a signaling lymphocytic activation molecule family receptor implicated in autoimmunity. J. Biol. Chem. 2008, 283:19255-19264.